title: MUC1 regulates nuclear localization and function of the epidermal growth factor receptor.
abstract: Alteration of protein trafficking and localization is associated with several diseases, including cystic fibrosis, breast cancer, colorectal cancer, leukemia and diabetes. Specifically, aberrant nuclear localization of the epidermal growth factor receptor (EGFR), a receptor tyrosine kinase, is a poor prognostic indicator in several epithelial carcinomas. It is now appreciated that in addition to signaling from the plasma membrane, EGFR also trafficks to the nucleus, and can directly bind the promoter regions of genes encoding cyclin D1 (CCND1) and B-Myb (MYBL2). We have previously established that loss of MUC1 in an EGFR-dependent transgenic mouse model of breast cancer correlates with the loss of cyclin D1 expression. Here, we provide evidence for a novel regulatory function of MUC1 in the trafficking and nuclear activity of EGFR. We found that MUC1 and EGFR interact in the nucleus of breast cancer cells, which promotes the accumulation of chromatin-bound EGFR. Additionally, the presence of MUC1 results in significant colocalization of EGFR and phosphorylated RNA polymerase II, indicating that MUC1 influences the association of EGFR with transcriptionally active promoter regions. Importantly, we found that the loss of MUC1 expression resulted in a decrease in the interaction between EGFR and the CCND1 promoter, which translated to a significant decrease in cyclin D1 protein expression. This data offers insights into a novel regulatory mechanism of EGFR nuclear function and could have important implications for evaluating nuclear localization in cancer.
authors.affiliation: Arizona Cancer Center, University of Arizona, Tucson, AZ 85724, USA.
authors.forename: Benjamin G
authors.initials: BG
authors.lastname: Bitler
authors.forename: Aarthi
authors.initials: A
authors.lastname: Goverdhan
authors.forename: Joyce A
authors.initials: JA
authors.lastname: Schroeder
mesh_terms: D021581:Active Transport, Cell Nucleus / Q000235:genetics; D001943:Breast Neoplasms / Q000235:genetics / Q000378:metabolism* / Q000473:pathology; D002277:Carcinoma / Q000235:genetics / Q000378:metabolism* / Q000473:pathology; D018797:Cell Cycle Proteins / Q000235:genetics / Q000378:metabolism; D045744:Cell Line, Tumor; D002467:Cell Nucleus / Q000378:metabolism*; D003001:Cloning, Molecular; D019938:Cyclin D1 / Q000235:genetics / Q000378:metabolism; D066246:ErbB Receptors / Q000378:metabolism*; D005260:Female; D006801:Humans; D018396:Mucin-1 / Q000235:genetics / Q000378:metabolism*; D011401:Promoter Regions, Genetic; D011485:Protein Binding / Q000235:genetics; D034741:RNA, Small Interfering / Q000235:genetics; D015534:Trans-Activators / Q000235:genetics / Q000378:metabolism
chemical_list: D018797:Cell Cycle Proteins; C064352:MYBL2 protein, human; D018396:Mucin-1; D034741:RNA, Small Interfering; D015534:Trans-Activators; D019938:Cyclin D1; C512478:EGFR protein, human; D066246:ErbB Receptors
references.citation: Mol Carcinog. 2009 Jul;48(7):610-7
references.pmid: 19058255
references.citation: Nucleic Acids Res. 2008 May;36(8):2594-607
references.pmid: 18334532
references.citation: Clin Cancer Res. 2004 Nov 15;10(22):7764-74
references.pmid: 15570011
references.citation: Cancer. 2001 Jun 1;91(11):1973-82
references.pmid: 11391575
references.citation: J Cell Biochem. 2006 Aug 15;98(6):1570-83
references.pmid: 16552725
references.citation: Cancer Res. 2006 Aug 15;66(16):7976-82
references.pmid: 16912172
references.citation: J Cell Biol. 2002 Jun 10;157(6):929-39
references.pmid: 12045181
references.citation: Mol Biol Cell. 2007 Mar;18(3):1064-72
references.pmid: 17215517
references.citation: Cancer Biol Ther. 2003 Nov-Dec;2(6):702-6
references.pmid: 14688481
references.citation: Cancer Res. 2009 Sep 1;69(17):7013-21
references.pmid: 19706766
references.citation: Nat Cell Biol. 2001 Sep;3(9):802-8
references.pmid: 11533659
references.citation: Oncology (Williston Park). 2008 Oct;22(11):1233-9; discussion 1239-40, 1243
references.pmid: 18980022
references.citation: Oncogene. 2004 Jul 29;23(34):5739-47
references.pmid: 15221004
references.citation: J Clin Invest. 1998 Jan 15;101(2):344-52
references.pmid: 9435306
references.citation: Cancer Cell. 2004 Sep;6(3):251-61
references.pmid: 15380516
references.citation: Mol Cancer Res. 2003 Aug;1(10):765-75
references.pmid: 12939402
references.citation: Cancer Res. 1994 Apr 1;54(7):1812-7
references.pmid: 8137296
references.citation: Pharm Res. 2007 Jan;24(1):17-27
references.pmid: 16969692
references.citation: Electrophoresis. 1994 Feb;15(2):265-77
references.pmid: 8026443
references.citation: J Cell Biol. 1996 Jul;134(2):529-36
references.pmid: 8707835
references.citation: Science. 2001 Dec 7;294(5549):2179-81
references.pmid: 11679632
references.citation: Mol Cell. 2006 Jan 20;21(2):295-305
references.pmid: 16427018
references.citation: J Biol Chem. 1993 Oct 5;268(28):21364-71
references.pmid: 8407976
references.citation: J Biol Chem. 2007 Jul 6;282(27):19321-30
references.pmid: 17500061
references.citation: J Biol Chem. 1990 Sep 5;265(25):15294-9
references.pmid: 2394722
references.citation: J Biol Chem. 1996 Jan 26;271(4):2332-40
references.pmid: 8567697
references.citation: Cancer Cell. 2008 May;13(5):385-93
references.pmid: 18455122
references.citation: Oncogene. 2007 Mar 15;26(12):1693-701
references.pmid: 16983337
references.citation: Genes Dev. 2007 Nov 15;21(22):2908-22
references.pmid: 18006686
references.citation: Nat Rev Mol Cell Biol. 2005 Feb;6(2):112-26
references.pmid: 15687999
references.citation: J Biol Chem. 2003 Sep 26;278(39):38029-39
references.pmid: 12832415
references.citation: J Biol Chem. 2001 Apr 20;276(16):13057-64
references.pmid: 11278868
references.citation: Cancer Res. 2007 Jul 15;67(14):6591-8
references.pmid: 17638868
references.citation: Cancer Res. 2009 Aug 1;69(15):6179-83
references.pmid: 19602593
references.citation: J Biol Chem. 2002 Oct 11;277(41):38284-93
references.pmid: 12161422
references.citation: J Biol Chem. 2007 Apr 6;282(14):10432-40
references.pmid: 17283074
references.citation: Cancer Res. 1995 Sep 1;55(17):3915-27
references.pmid: 7641211
references.citation: Biochem Biophys Res Commun. 1999 Mar 5;256(1):192-7
references.pmid: 10066445
references.citation: Int J Oncol. 2008 Dec;33(6):1165-76
references.pmid: 19020749